European Pharmaceutical Review
DECEMBER 12, 2023
He discusses why NK cell therapy’s ability to generate ‘synthetic immunity’ in the body means this modality holds potential as an anti-cancer treatment. We specialise in the development of new cutting-edge immunotherapies , based on the use of therapeutic antibodies capable of activating the immune system to fight cancer.
pharmaphorum
NOVEMBER 29, 2022
Amplifying and reinvigorating persistent T cell immunity has become a much-needed path to enhance anti-tumor efficacy. T cells are known to mediate anti-tumor immune responses. For that reason, they have become the key target of immune checkpoint therapies, like PD-(L)1 agents. About the interviewee. He received his Ph.D.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog: Biosimilars
APRIL 30, 2023
Senate Committee on Health, Education, Labor and Pensions (“Senate HELP”) is scheduled to take up legislation that could significantly limit access to the courts and immunize critical FDA decisions from timely judicial review. Subsection 505(q) initially was added by Section 914 of the 2007 FDA Amendments Act (“FDAAA”), Pub.
Big Molecule Watch
MARCH 9, 2023
Born one hundred years ago, Dr. Askonas contributed to our understanding of the origin and synthesis of antibodies and the body’s immune response. In 2007, she was awarded the Robert Koch Gold Medal, the leading international scientific prize in microbiology, and in 2012, an Honorary Doctorate by Cambridge University.
The Thyroid Pharmacist
JUNE 30, 2023
However, low doses of this medication (hence, low dose naltrexone or LDN), have been found to modulate the immune system and have shown promise in improving cases of autoimmune disease. These include Crohn’s, MS, and Hashimoto’s, as well as other immune system-related conditions such as cancer and HIV/AIDS. Doses of 1.5-4.5
pharmaphorum
OCTOBER 12, 2022
Similar to how we injected mRNA into people to trigger an immune response and train their immune system against COVID-19, genomic medicine repairs cellular or molecular mechanisms that are dysfunctional and cause disease.”. We believe that genomic therapies are going to be important arms in our arsenal to treat many diseases.”.
Putting Patients First Blog
JUNE 13, 2023
During the crisis of the 1980s, the spread of the human immunodeficiency virus (HIV) was coined by health care professionals as the “gay cancer” and Gay-Related Immune Deficiency (GRID), adding societal stigma and hysteria against LGBTQ+ individuals. Grove Press, 2007. [2] References [1] Kaiser, Charles. 2] Streed Jr, Carl G.,
Expert insights. Personalized for you.
124 
Let's personalize your content